Living with HIV, Dying of TB - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Living with HIV, Dying of TB

Description:

... can rule out active TB disease is needed and how best to link it with IPT? ... reported weight loss. CXR increased the sensitivity of the screening. Algorithm ... – PowerPoint PPT presentation

Number of Views:15
Avg rating:3.0/5.0
Slides: 21
Provided by: Lam133
Category:
Tags: hiv | dying | living

less

Transcript and Presenter's Notes

Title: Living with HIV, Dying of TB


1
Living with HIV, Dying of TB Intensified TB case
finding among people living with HIV
Adapted from presentation by Colleen
Daniels TB/HIV Advocacy Stop TB Department, WHO
2
Outline of presentation
  • What is intensified case finding?
  • Global implementation of TB case finding
  • Challenges
  • Conclusions

3
Intensified Case Finding (ICF)
  • Intensified TB case finding (ICF) is an activity,
    recommended by the World Health Organization
    (WHO), intended to detect possible TB cases as
    early as possible among people living with HIV
  • Screening for symptoms and signs of TB
  • TB treatment
  • TB sputum smear
  • - IPT
  • ICF is the first step towards making a TB
    diagnosis.

4
Intensified Case Finding (ICF)
  • TB control programs generally rely on passive TB
    case finding
  • People living with HIV are at much greater risk
    of getting TB and if not treated soon enough,
    dying from it
  • often aggressive cases including hard-to-diagnose
    smear-negative or extrapulmonary disease.
  • ICF consists of using a simple questionnaire
    looking for the signs and symptoms of TB.

5
Percentage of PLHIV screened for TB in countries
with 80 of the global burden, 2006.
6
Proportion of PLHIV screened and diagnosed with
TB in selected countries, 2006
29
8
20
31
7
Country Screening Tools
8
National screening strategy Kenya
  • Symptoms and signs
  • Adults (any of)
  • 1. Cough (of any duration)?
  • 2. Blood stained sputum?
  • 3. Night sweats gt2 weeks
  • 4. Fever ?
  • 5. Weight loss?
  • 6. Chest pain?
  • 7. Breathlessness?
  • 8. Fatigue?
  • 9. History of previous TB treatment?
  • 10. History of close contact with a person
    confirmed to have TB?
  • 11. Swellings in the neck, armpits or elsewhere?
  • 12 Diarrhea for more than two weeks?
  • Symptom and signs
  • Children (any of)
  • 1. Cough (of any duration)?
  • 2. Blood stained sputum?
  • 3. Night sweats gt2 weeks
  • 4. Fever? Of any duration?
  • 5. Weight loss?
  • 6. Chest pain?
  • 7. Fast Breathing?
  • 8. Fatigue?
  • 9. History of previous TB treatment?
  • 10. History of close contact with a person
    confirmed to have TB?
  • 11. Swellings in the neck, armpits or elsewhere?
  • 12 Diarrhea for more than 2 weeks?
  • 13. Failure to thrive?

9
National screening strategy Malawi
  • Any of the following
  • Cough more than 3wks
  • Weight loss
  • Fever or night sweats
  • Fatigue/tiredness
  • Loss of appetite
  • Lymph node enlargement

10
Screening tools in countries
  • Screening tools vary from country to country
  • More and more non-specific constitutional
    symptoms and signs included in tools
  • Children are not addressed
  • Presence of nationally recommended screening tool
    does not always guarantee implementation

11
Challenge implementation issues
  • Standardised screening tool needed?
  • Screening tool that can rule out active TB
    disease is needed and how best to link it with
    IPT?
  • Who administers the standard tool and where?
  • How often should it be administered?
  • Monitoring and evaluation- how should it be
    recorded and reported?

12
Review of some published evidence of TB screening
strategies
13
Kimerling, et.al Cambodia,2002IJTLD 2002
6988994
14
Day, et. al. South Africa, 2006IJTLD 2006
10523-529
15
Demissie, et.al. EthiopiaWorld Lung Health
Conference 2007 Abstract S11
16
Some Notes and Observations from available
evidence
  • Sesitivity Ability of the test to accurately
    diagnose the presence of disease.
  • Specificity Ability of the test to accurately
    identify all people without the condition
  • These are both measures of accuracy of a
    screening tool to identify a person with TB, the
    higher the Sensitivity and Specificity the more
    accurate the tool.
  • The accuracy of screening are generally
    inconsistent and dependent what types of
    screening questions are asked. Eg the more the
    symptoms the greater the chances of detecting
    anyone with TB, but also the greater the chances
    of wrongly suspecting that people have TB when
    they dont.
  • Chronic cough more than 2 or 3 wks alone looks
    insensitive predictor of TB in PLHIV
  • Role of CXR is not clear and inconsistent

17
Living with HIV, Dying of TB Conclusions
  • People with HIV have the right to ask for TB
    screening and diagnosis.
  • Check your country's progress in implementing the
    12 collaborative activities and engage with the
    NTP and NAP to call for scale up (Global TB
    Report)

18
Conclusions
  • Mobilization by civil society urgently needed to
    scale up ICF.
  • Community driven to create demand
  • Educate increase literacy in communities and at
    health care facilities
  • Work with joint TB/HIV national mechanisms to
    rapidly scale up
  • Engage in processes such as Global Fund CCMs
  • Demand creation
  • Myth busting - ensure that arguments about
    challenges to implementation are not a barrier
    (HIV experience) - Just do it!

19
Conclusions
  • Massive research efforts to develop the best and
    feasible screening tool are urgently needed
  • "TB dipstick test"- simple and rapid tool is
    crucial
  • Call for investment and increase in laboratory
    capacity and call for adequate referral systems
  • Recording and reporting

20
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com